One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms

URL

https://www.mdpi.com/2077-0383/10/15/3305

Authors

Andreas Rank, Athanasia Tzortzini, Elisabeth Kling, Christoph Schmid, Rainer Claus, Eva Löll, Roswitha Burger, Christoph Römmele, Christine Dhillon, Katharina Müller, Philipp Girl, Reinhard Hoffmann, Stefanie Grützner, and Kevin M. Dennehy

Published Date

July 27, 2021

Publication

Journal of Clinical Medicine

Organization

University of Augsburg, Germany

Key Excerpts

“Abstract: … This study focused on mild COVID-19 and investigated correlations of immunity with persistent symptoms and immune longevity… Activation-induced marker assays identified specific T-helper cells and central memory T-cells in 80% of participants at a 12-month follow-up.”

All articles published by MDPI are made immediately available worldwide under an open access license. This means: everyone has free and unlimited access to the full-text of all articles published in MDPI journals; everyone is free to re-use the published material if proper accreditation/citation of the original publication is given; Source: https://www.mdpi.com/openaccess

Medium

document

Topics

natural immunity